On November 12, 2020 Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, reported that company management will participate at three upcoming conferences (Press release, Xencor, NOV 12, 2020, View Source [SID1234570835]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Virtual London Healthcare Conference
Conference Dates: November 17-19, 2020
Presentation Date: Thursday, November 19, 2020
Presentation Time: 5:00 p.m. GMT / 9:00 a.m. PST
SVB Leerink Oncology Day
Conference Date: Thursday, November 19, 2020
Piper Sandler 32nd Annual Virtual Healthcare Conference
Conference Dates: November 30 – December 3, 2020
Presentation Available: Monday, November 23, 2020
Webcasts of the Jefferies and Piper Sandler presentations will be available under "Events & Presentations" in the Investors section of the Company’s website located at www.xencor.com. A replay of the live Jefferies presentation will be posted on the Xencor website approximately one hour after the live event. Both presentations will be available for at least 30 days.